Cover Image

Virtual Weight Management and Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Randomized Controlled Trial

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Peter T. Katzmarzyk, Kimberly Drews, Jamy D. Ard, Tracey L. McLaughlin, Melissa N. Harris, Alexandra Lee, Gary D. Foster, Hyun Jung Lee, Timothy C. Dunn, Corby K. Martin, Frank L. Greenway, Michelle I. Cardel
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Obesity
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Twelve‐month analysis of real‐world evidence from a telehealth obesity‐treatment provider using antiobesity medications
by: Jamy D. Ard, et al.
Published: (2024)

The latest evidence and clinical guidelines for use of meal replacements in very‐low‐calorie diets or low‐calorie diets for the treatment of obesity
by: Shenelle A. Edwards‐Hampton, et al.
Published: (2024)

Computed Tomography and Dual‐Energy X‐Ray Asorptiometry body composition parameter harmonisation to universalise adipose tissue measurements in a population‐based cross‐sectional study
by: Elliot T. Varney, et al.
Published: (2024)

Effects of a 2‐Year Primary Care Weight Loss Intervention on Quality of Life in Patients With Obesity
by: Kara D. Denstel, et al.
Published: (2026)

Perceptions of anti‐obesity medications among people with obesity and healthcare providers in the US: Findings from the OBSERVE Study
by: Lee M. Kaplan, et al.
Published: (2025)

Response to Hayashi et al.
by: Corby K. Martin, et al.
Published: (2025)

Exploring the Role of Internalized Weight Bias as a Metric of Cumulative Social Disadvantage Among People With Obesity or Overweight: Insights From the OBSERVE Study
by: Jamy Ard, et al.
Published: (2025)

Application of the Lancet Commission Criteria for the Diagnosis of Obesity to a Clinical Trials Population: The LEAP Trial
by: Faith Anne N. Heeren, et al.
Published: (2025)

Efficacy and safety of a novel oral hydrogel capsule in adults with overweight or obesity: the pivotal randomized RESET study
by: Jamy D. Ard, et al.
Published: (2025)

Efficacy of Oral Antiobesity Medications With Versus Without Adjunct Behavioral Weight Management Treatment
by: Rebecca A. Jones, et al.
Published: (2026)

Adolescent experiences of weight‐related communication: Sociodemographic differences and the role of parents
by: Leah M. Lessard, et al.
Published: (2024)

Effectiveness of Telemedicine Prescribing and a Long‐Acting Obesity Medication Behavioral Program: A 24‐Week Single‐Arm Study
by: Leslie J. Heinberg, et al.
Published: (2025)

GLP1Ra‐based therapies and DXA‐acquired musculoskeletal health outcomes: a focused meta‐analysis of placebo‐controlled trials
by: Kristen M. Beavers, et al.
Published: (2024)

A Novel Method to Evaluate Insulin Sensitivity by Combining Continuous Glucose Monitoring and Urinary C‐Peptide Excretion
by: Guillermo Sanchez‐Delgado, et al.
Published: (2026)

Psychosocial Outcomes in Telemedicine and Long‐Acting Incretin‐Specific Behavioral Intervention
by: Leslie J. Heinberg, et al.
Published: (2026)

Nutritional considerations with antiobesity medications
by: Jaime P. Almandoz, et al.
Published: (2024)

Response to the Letter to the Editor by Bett et al.
by: Jaime P. Almandoz, et al.
Published: (2024)

Response to the Letter to the Editor by Athinarayanan
by: Jaime P. Almandoz, et al.
Published: (2024)

Glucagon‐like peptide ‐1 receptor agonist ‐based agents and weight loss composition: Filling the gaps
by: Robert L. Dubin, et al.
Published: (2024)

Comparative Weight Change With Initiation and Adherence to Common Medications for Type 2 Diabetes
by: Nadia M. Sneed, et al.
Published: (2025)

Tirzepatide for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN
by: Deborah B. Horn, et al.
Published: (2025)

Four‐year follow‐up of weight loss maintenance using electronic medical record data: The PROPEL trial
by: Peter T. Katzmarzyk, et al.
Published: (2024)

Clarification of our response to “The importance of diversity in Obesity articles”
by: Michelle Cardel, et al.
Published: (2024)

Glucose‐Dependent Insulinotropic Polypeptide and Glucagon After Weight Loss Induced by Diet or Bariatric Surgery
by: Amanda Finn, et al.
Published: (2025)

Impact of Real Time, Flash and Retrospective Continuous Glucose Monitoring on Feto‐Maternal Outcomes in Women With Gestational Diabetes and Pre‐Gestational Diabetes: A Systematic Review and Meta‐Analysis With Trial Sequential Analysis of Randomized Controlled Trials
by: Deep Dutta, et al.
Published: (2026)

Valuing behavioral interventions for obesity reduction: A scoping review of economic models
by: Joanna McLaughlin, et al.
Published: (2024)

Estimated Glucose Disposal Rate and Risk of Vascular Events and Death in Type 2 Diabetes in the ADVANCE Study
by: Ruirui Wang, et al.
Published: (2026)

How Do Trauma‐ and Violence‐Informed Care Approaches Underpin Bariatric Surgery Interventions for Type 2 Diabetes Mellitus Remission? A Scoping Review
by: Michelle Greenway, et al.
Published: (2025)

The One‐Hour Oral Glucose Tolerance Test to Predict Glucose Intolerance Postpartum in Women With Prior Gestational Diabetes
by: Niels Bochanen, et al.
Published: (2026)

Association of Obesity Severity With Cardiometabolic and Renal Disease Burden in the United States
by: Florina Corpodean, et al.
Published: (2025)

Stem Cell Secretome Treatment Reduces Adiposity and Improves Glucose Handling During Obesity and Weight Loss in Mice
by: Zachary J. Fennel, et al.
Published: (2025)

Efficacy and Safety of Tirzepatide on Weight Loss in Patients Without Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
by: Sharath Kommu, et al.
Published: (2025)

Cardiorenal Outcomes of Sodium–Glucose Cotransporter 2 Inhibitors in Type 2 Diabetes Mellitus With Nephrotic‐Range Proteinuria: A Multi‐Institutional Target Trial Emulation
by: Jia‐Jin Chen, et al.
Published: (2026)

Early Weight Loss and Other Factors Associated With Clinically Significant Weight Loss in Two Commercial Weight Loss Programmes
by: Christopher D. Coleman, et al.
Published: (2025)

GLP‐1 Receptor Agonists and Substance Use Disorders in Older Adults With Type 2 Diabetes: A Target Trial Emulation
by: Hao Dai, et al.
Published: (2025)

The Impact of Baseline Sleep as a Potential Moderator of Weight Loss Intervention in Breast Cancer Survivors: Results From the POWER ‐Remote Trial
by: Jennifer Y. Sheng, et al.
Published: (2025)

Long‐Term Weight Loss Outcomes in a Virtual Weight Care Clinic Prescribing a Broad Range of Medications Alongside Behavior Change
by: Jennifer M. Clark, et al.
Published: (2025)

Dapagliflozin‐Associated Reduction in Liver Fat Is Independent of Weight Loss in Patients With Type 2 Diabetes
by: Anna V. Naumova, et al.
Published: (2026)

Effectiveness and Safety of Finerenone in Patients With Diabetic Kidney Disease: A Real‐World Observational Study
by: Jaehyun Bae, et al.
Published: (2026)

Impact of Genetic Predisposition to Obesity on Long‐Term Maintenance of Modest Weight Loss in Postmenopausal Women
by: Harold H. Lee, et al.
Published: (2026)